Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial …

STATEN ISLAND, N.Y., May 2, 2024 /PRNewswire/ — Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”), a clinical stage …

Do you trust this headline?

Based on recent headline ratings, 100% of this readership currently trusts the local media, which has an average score of 70% regionally and is currently trending positive.

100%

Media Trust Score100%